| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Oncopeptides AB (publ) (ST: ONCO)
ONCO Technical Analysis
5
| As on 24th Jan 2025 ONCO STOCK Price closed @ 1.35 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 8.18 & Strong Sell for SHORT-TERM with Stoploss of 10.87 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ONCOSTOCK Price
| Open | 1.30 | Change | Price | % |
| High | 1.35 | 1 Day | 0.05 | 3.85 |
| Low | 1.29 | 1 Week | -0.03 | -2.17 |
| Close | 1.35 | 1 Month | -0.16 | -10.60 |
| Volume | 461259 | 1 Year | -9.72 | -87.80 |
| 52 Week High 13.05 | 52 Week Low 1.34 | ||||
ST Sweden Most Active Stocks
| FING-B | 0.02 | -33.33% |
| ATORX | 0.05 | -70.59% |
| ERIC-B | 85.20 | -12.72% |
| WYLD | 0.01 | 0.00% |
| SBB-B | 5.29 | 0.19% |
| DIABIO | 0.01 | -50.00% |
| HDW-B | 0.00 | % |
| LUNE | 21.97 | 6.65% |
| QLINEA | 0.30 | 0.00% |
| SNM | 0.94 | 2.17% |
ST Sweden Top Gainers Stocks
ST Sweden Top Losers Stocks
| ONCO Daily Charts |
ONCO Intraday Charts |
Whats New @ Bazaartrend |
ONCO Free Analysis |
|
|
ONCO Important Levels Intraday
| RESISTANCE | 1.47 |
| RESISTANCE | 1.43 |
| RESISTANCE | 1.41 |
| RESISTANCE | 1.38 |
| SUPPORT | 1.32 |
| SUPPORT | 1.29 |
| SUPPORT | 1.27 |
| SUPPORT | 1.23 |
ONCO Forecast January 2025
| 4th UP Forecast | 11.29 |
| 3rd UP Forecast | 8.1 |
| 2nd UP Forecast | 6.13 |
| 1st UP Forecast | 4.16 |
| 1st DOWN Forecast | -1.46 |
| 2nd DOWN Forecast | -3.43 |
| 3rd DOWN Forecast | -5.4 |
| 4th DOWN Forecast | -8.59 |
ONCO Weekly Forecast
| 4th UP Forecast | 7.71 |
| 3rd UP Forecast | 5.67 |
| 2nd UP Forecast | 4.41 |
| 1st UP Forecast | 3.15 |
| 1st DOWN Forecast | -0.45 |
| 2nd DOWN Forecast | -1.71 |
| 3rd DOWN Forecast | -2.97 |
| 4th DOWN Forecast | -5.01 |
ONCO Forecast2025
| 4th UP Forecast | 26.46 |
| 3rd UP Forecast | 18.41 |
| 2nd UP Forecast | 13.43 |
| 1st UP Forecast | 8.45 |
| 1st DOWN Forecast | -5.75 |
| 2nd DOWN Forecast | -10.73 |
| 3rd DOWN Forecast | -15.71 |
| 4th DOWN Forecast | -23.76 |
Oncopeptides AB (publ) ( ST Sweden Symbol : ONCO )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ONCO Business Profile
Oncopeptides AB (publ), a biotech company, develops pharmaceuticals drugs for the treatment of cancer in the United States, Europe, Canada, Japan, China, and internationally. Its lead product candidate is melflufen, an anti-cancer peptide drug conjugate for the treatment of relapsed refractory multiple myeloma in adult patients. The company was incorporated in 2000 and is headquartered in Stockholm, Sweden. Address: Vastra Tradgardsgatan 15, Stockholm, Sweden, 111 53
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service